Loading
Legend Biotech Corp Stock: price and insider trades · United States
Insider Decl.
18
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€418,328
4 ops. · all time
Who traded when
BuySaleHuang Ying2 sales
Carlos E. Santos1 sale
Corazon (Corsee) D. Sanders1 sale
Analyst consensus: bullish or bearish?
Analysts rate Legend Biotech Corp Buy (bullish), based on 13 analysts. Average price target: US$45.62.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 21,668 of 26,250 companies
28.6
score / 100
Value22
Quality35
FCF yld-3.6%
Earn yld-8.2%
EV/EBITDA·
ROE-8.1%
Gross mgn60%
Net mgn-29%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$18.65
Analyst consensus
13 analystsBuy
US$24.00Target US$45.62(+145%)US$68.00
Income statement
RevenueUS$1B
Gross profitUS$620.8M60% margin
EBITDA-US$232.3M-23% margin
Net income-US$296.8M-7.2% margin
Valuation
PER (forward)17.8x
P/Book2.9x
Beta0.57
Balance sheet & cash
Market capUS$3.6B
Total debtUS$413.7M
Free Cash Flow-US$128.8M
Debt / Equity23%
Profitability & ownership
ROE-8.1%
ROA-1.9%
% insiders1.9%
% institutions55.8%
Last declaration on 1 October 2026
Declarations18 total
27,370 shares@ US$9.460.0071% mcap50.0% of flowOrdinary SharesSEC:0001796536-26-000010:0
13,685 shares@ US$18.91960.0071% mcap100.0% of flowAmerican Depositary SharesSEC144:0001959173-26-007138
28,330 shares0Ordinary SharesSEC:0001974687-26-000006:0
20,986 shares0Ordinary SharesSEC:0001796536-26-000009:0
28,330 shares0Ordinary SharesSEC:0002088468-26-000006:0
20,986 shares0Ordinary SharesSEC:0002106809-26-000005:0
20,986 shares0Ordinary SharesSEC:0002068365-26-000009:0
20,986 shares0Ordinary SharesSEC:0001814673-26-000005:0
19,676 shares0Ordinary SharesSEC:0002097065-26-000005:0
5,430 shares@ US$9.140.0013% mcap49.4% of flowOrdinary SharesSEC:0002097065-26-000005:1
69,812 shares@ US$18.65170.035% mcap88.7% of flowAmerican depositary sharesSEC144:0001959173-26-007076
2,715 shares@ US$18.73080.0014% mcap50.6% of flowAmerican Depositary SharesSEC144:0001959173-26-007077
1,131,860 shares0Ordinary SharesSEC:0001964342-26-000004:0
4,908 shares0Ordinary SharesSEC:0001908421-26-000005:0
3,000 shares@ US$29.600.0024% mcap100.0% of flowAmerican Depositary SharesSEC144:0001959173-26-004966
5,566 shares@ US$14.785.4% of flowOrdinary SharesSEC:0001967360-26-000006:0
2,783 shares@ US$28.39270.0015% mcap5.4% of flowAmerican Depositary SharesSEC144:0001959173-26-004918
9,936 shares@ US$8.775.9% of flowOrdinary SharesSEC:0001967360-26-000004:0
18 of 18 declarations
About Legend Biotech Corp
All 18 filings at Legend Biotech Corp date from 2026 and include 4 open-market sales worth EUR 418,328, with a median of EUR 73,715, and no purchase. The largest sale is Corazon (Corsee) D. Sanders's (Director), EUR 227,694 on September 29, 2026. Ying Huang (Chief Executive Officer) sold EUR 75,025 on March 25, 2026 and EUR 72,406 on June 25, 2026.
The other filings include 9 grants and 5 filings of another nature. The record mixes several spellings of the same names: Corazon (Corsee) D. Sanders also appears as Sanders Corazon (Corsee) D., and Ying Huang as Huang Ying, here with the title Former Officer & Director. Carlos E. Santos (Chief Financial Officer) has 2 filings including 1 sale. In all, 14 filers are recorded.
Read moreShow less
The US health care company, listed on Nasdaq, is valued at USD 3.63 billion, with 1.9% held by insiders. Filings cover trades from March 25, 2026 to September 29, 2026, a median of 2 days after the trade, and all fall within the last twelve months.
